ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN was delisted on the 18th of July, 2024.
12 hedge funds and large institutions have $8.25M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
2,709% more capital inflows, than outflows
Capital inflows: $5.48M | Capital outflows: $195K
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
71% more funds holding
Funds holding: 7 → 12 (+5)
4.14% more ownership
Funds ownership: 4.9% → 9.04% (+4.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ikarian Capital
Dallas,
Texas
|
+$3.68M |
| 2 |
Temasek Holdings
Singapore
|
+$469K |
| 3 |
Renaissance Technologies
New York
|
+$453K |
| 4 |
Boothbay Fund Management
New York
|
+$388K |
| 5 |
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$161K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DAFNA Capital Management
Los Angeles,
California
|
-$164K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31K |
ASLN Hedge Fund Activity: Q4 2020 in Review
12 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q4 2020, worth a combined $8.25M — up 27% from $6.48M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ASLN positions and 2 closed out — a net gain of 5 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $3.68M. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $164K sold.
- 12 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q4 2020, up from 7 in Q3 2020.
- Funds reported $8.25M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q4 2020, up 27% quarter-over-quarter.
- 7 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q4 2020 and 2 closed out, a net change of +5 holders.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q4 2020 was Ikarian Capital, an estimated $3.68M added.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q4 2020 was DAFNA Capital Management, an estimated $164K sold.
Based on aggregated 13F filings for Q4 2020.